NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Advent received development grants from the U.K. based on its independence from NWBO

Doc logic,

IMO, Northwest Biotherapeutics got the funding from the Cambridgeshire and Peterborough Development Authority.

Phase 1a cost approximately £3.5 million ($4.6 million), including the double shift costs, and covered the support facilities for the first two manufacturing suites, which had already been built. Approximately £1.35 million ($1.77 million) of the Phase 1a cost was funded through a competitive loan from the Cambridgeshire and Peterborough Development Authority. This funding was instrumental in enabling the Sawston facility to reach initial manufacturing readiness. The Company is very grateful to the Development Authority for this funding, and is looking forward to continuing to work with the Authority.

https://nwbio.com/northwest-biotherapeutics-announces-development-completed-for-initial-production-capacity-of-sawston-uk-facility/